2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19

D Farge, C Frere, JM Connors, AA Khorana… - The Lancet …, 2022 - thelancet.com
Summary The International Initiative on Thrombosis and Cancer is an independent
academic working group of experts aimed at establishing global consensus for the treatment …

Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade

A Charpidou, G Gerotziafas, S Popat, A Araujo… - Cancers, 2024 - mdpi.com
Simple Summary Thrombotic events are a common problem for lung cancer patients.
Compared to other types of cancer, lung cancer patients are more likely to experience blood …

Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art

E Dimakakos, G Gomatou, M Catalano… - Anticancer …, 2022 - ar.iiarjournals.org
Cancer and COVID-19 are both well-established risk factors predisposing to thrombosis.
Both disease entities are correlated with increased incidence of venous thrombotic events …

[HTML][HTML] Risk of arterial and venous thrombotic events among patients with cancer diagnosed with COVID-19: A real-world data analysis

JW Law, C Zhang, D Idyro, JL Weese, A Schrag… - Thrombosis …, 2024 - Elsevier
Aim The risk of venous thromboembolism (VTE) and arterial thrombosis events (ATE) and
potential corresponding risk factors were assessed in patients with cancer diagnosed with …

COVID-19 impact on thrombotic complications in cancer patients

AV Vorobev, SE Einullaeva, AS Borodulin… - Obstetrics, Gynecology …, 2024 - gynecology.su
Aim: to study the features of thrombotic complications in cancer patients during COVID-19
infection, and identify the most significant diagnostic and prognostic criteria. Materials and …

[引用][C] Влияние COVID-19 на тромботические осложнения у онкологических больных

АВ Воробьев, СЭ Эйнуллаева… - Акушерство …, 2024 - IRBIS LLC